Suchergebnisse

Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Author -- Introduction -- Section 1 Meaningful Healthcare Experiences -- 1 Meaning in Life as Meaning in Healthcare -- Meaning in Life -- Meaning in Work -- Meaning in Healthcare -- Summary -- 2 Meaningful Healthcare Experiences for People Receiving Care -- 3 Meaningful Healthcare Experiences for People Delivering Care -- 4 Proxemics, Emotions, Power, and Generations in Meaningful Healthcare Experiences -- Proxemics and Meaningful Experience Design -- Emotions and Meaningful Experience Design -- Power and Meaningful Experience Design -- Generations and Meaningful Experience Design -- Summary -- Section 2 Designing Meaningful Healthcare Experiences -- 5 A Healthcare Experience -- 6 Healthcare Service Processes from a Sociotechnical Perspective -- 7 The Three Value Streams of American Healthcare Experiences -- 8 Organizational Process Value Stream -- 9 The Value Stream of People Receiving Care -- 10 The Value Stream of People Delivering Care -- 11 Meaningful Healthcare Experience Design Map -- Section 3 Implementing Meaningful Healthcare Experience Design in Organizations -- 12 Meaningful Experience Design as the Foundation of Healthcare Quality -- 13 Aligning Organizational Structures for Meaningful Experience Design -- Structure for People Receiving Care -- Structure for People Delivering Care -- Organizational Structure -- 14 Introducing Meaningful Healthcare Experience Design into Healthcare Organizations -- Step 1 - Senior Leadership Appoints a Small Taskforce to Explore Meaningful Experience Design and to Develop a Proposal for Leadership to Review and Approve -- Step 2 - Integrate Organizational Structures to Support Meaningful Experience Design -- Step 3 - Develop Training Materials for Meaningful Experience Design.

chapter 1 A Brief History of American Healthcare -- chapter 2 Healthcare Quality History -- chapter 3 Quality- Driven Healthcare -- chapter 4 Industrialized Healthcare and Organizational Transitions -- chapter 5 A Vision of 21st Century Healthcare -- chapter 6 What Does It All Mean to You?.

National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community. The GenRe-Mekong project is funded by the Bill and Melinda Gates Foundation (OPP11188166, OPP1204268). Genotyping and sequencing were funded by the Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z) and Medical Research Council (G0600718). A proportion of samples were collected with the support of the UK Department for International Development (201900, M006212), and Intramural Research Program of the National Institute of Allergy and Infectious Diseases.